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Tinosorb M® is a widely used UV filter
complex. Its active component, bisoc-
trizole, is solubilized by the surfactant
decyl glucoside.
Case Report
A 66-year-old male was observed with
1-year history of recurrent, pruriginous,
and erythematous plaques in his face
and neck, not related to his work (print-
ing industry), with transient improve-
ment on topical treatment.
Patch tests were performed with
the Portuguese Contact Dermatitis
Study Group baseline series, with an
extended cosmetic and photo-allergen
series, including the UV filters pro-
vided for the European Multi-Centre
Photopatch Test Study. On D2/D4
there was only a positive reaction
(++) for Tinosorb M® (10% pet.),
with no further aggravation after
5 J/cm2 UV irradiation. This reaction
was considered relevant, as the patient
was regularly using a facial sunscreen
(Ave`ne®) containing Tinosorb M®
and lesions cleared on stopping its
application.
Further patch testing with decyl glu-
coside (5% pet.), several commercial
sunscreens, and other cosmetics con-
taining different glucosides (myristyl-,
coco-, lauryl-, arachidyl-, cetearyl- and
xylityl glucosides) revealed positive
reactions (++) to decyl glucoside,
Tinosorb M® and sunscreens con-
taining Tinosorb M®, and also all







phenol)) is an insoluble, photostable,
and poorly absorbed organic UV fil-
ter. It has been described as a weak
allergen, and its use is considered safe
and well tolerated. It is commercially
provided as Tinosorb M®, combined
with propylene glycol, xantham gum,
and decyl glucoside.
Decyl glucoside (CAS 58846-77-8)
is a mild non-ionic surfactant used as a
cleansing agent; despite being widely
used and having a low allergic poten-
tial (1), it has rarely been associated
with allergic contact dermatitis (2, 3,
4, 5). As a component of Tinosorb
M®, decyl glucoside has been identi-
fied as the responsible allergen in the
present case, as in similar cases (2).
In another published case of allergic
contact dermatitis from Tinosorb M®,
decyl glucoside was not tested (6).
Concomitant reactions to several
glucosides observed in this case may
be because of cross-reactivity between
these structurally similar molecules.
However, it is also important to stress
the possibility of the existence of other
glucosides, including decyl glucoside,
as impurities that persist in the gluco-
side solutions during their industrial
production. This might impose sig-
nificant limitations in daily routine in
patients allergic to decyl glucoside, as
they have to avoid both sunscreens
containing Tinosorb M® and several
other cosmetics containing glucosides.
The absence of decyl glucoside in
most cosmetic series for patch testing
and its recent commercial use in cos-
metics might contribute to an underes-
timation of its frequency as a contact
allergen.
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